EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics

Pingping Li iD, Mengyao Han, Rui Zhang, Fangyu Chen, Yanzi Li, Jing Yuan, Ning Ma, Lu Li iD, Jianhua Wu

PROTEOMICS – Clinical Applications · 2025

DOI: 10.1002/prca.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2025. Verfasst von Pingping Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aier Eye Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Choroidal Effusions, Glucocorticoids, Retinal Detachment, Anti-Inflammatory Agents. Die Arbeit nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glucocorticoids are widely used for their anti‐inflammatory properties, but their specific molecular mechanisms in treating rhegmatogenous retinal detachment with choroidal detachment (RRDCD) remain unclear. This study aims to identify key regulatory factors in the vitreous humor of RRDCD patients and analyze protein changes after hormonal intervention.

Methods

Vitreous fluid samples were collected during surgery from patients with rhegmatogenous retinal detachment (RRD, n = 40), non‐glucocorticoid treated RRDCD (nT‐RRDCD, n = 35), and glucocorticoid‐treated RRDCD (T‐RRDCD, n = 32). Primary outcomes were retinal reattachment status and best‐corrected visual acuity (BCVA) at 6 months postoperatively. Proteomic analysis was performed using data‐independent acquisition (DIA), with differentially expressed proteins validated by parallel reaction monitoring (PRM) and ELISA.

Results

Between RRD and nT‐RRDCD, 203 differentially expressed proteins were identified, while 295 proteins were differentially expressed between nT‐RRDCD and T‐RRDCD. These proteins were involved in complement activation, immune response, blood coagulation, and MAPK signaling. Apolipoprotein D (APOD) and vitronectin (VTN) positively correlated with postoperative BCVA. APOD, serum amyloid A‐4 (SAA4), and ubiquitin‐conjugating enzyme E2 variant emerged as potential diagnostic biomarkers for RRDCD.

Conclusions

RRDCD development involves multiple factors. Glucocorticoids mitigate retinal damage by suppressing inflammation, regulating oxidative stress, and promoting cell repair. APOD and VTN correlate with BCVA, while APOD, SAA4, and ubiquitin‐conjugating enzyme E2 show promise as diagnostic biomarkers for RRDCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal EffusionsGlucocorticoidsRetinal DetachmentAnti-Inflammatory AgentsAdultAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesMAP Kinase Signaling SystemOxidative StressProtein Interaction MapsProteomeProteomicsVitreous Body

Stichwörter der Autor:innen

biomarkerschoroidal detachmentglucocorticoids therapyinflammationquantitative proteomicsretinal detachment

Substanzen

GlucocorticoidsProteomeAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Aier Eye Hospital of Wuhan University, Wuhan, China.
  • Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Pingping Li, Lu Li

Zitieren

APA

Li, P., Han, M., Zhang, R., Chen, F., Li, Y., Yuan, J., Ma, N., Li, L., & Wu, J. (2025). Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.70008

Vancouver

Li P, Han M, Zhang R, Chen F, Li Y, Yuan J, et al. Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics. PROTEOMICS – Clinical Applications. 2025. doi:10.1002/prca.70008

BibTeX
@article{Li2025,
  author = {Li, Pingping and Han, Mengyao and Zhang, Rui and Chen, Fangyu and Li, Yanzi and Yuan, Jing and Ma, Ning and Li, Lu and Wu, Jianhua},
  title = {Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2025},
  doi = {10.1002/prca.70008}
}
Kostenlos starten →